Cassava Sciences Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while Invesco WilderHill Clean Energy ETF trades at $33.3. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | PBW | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.64 | $46.99 |
52-Week Low | $1.09 | $22.23 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
PBW trades at $33.22, down 5.03% today amid a bearish technical signal with moving averages indicating selling pressure. The ETF shows neutral momentum oscillators but faces resistance near $35. Recent news highlights clean energy sector tailwinds from energy security concerns and legislative support, though the fund remains sensitive to interest rate movements and semiconductor market volatility.
Outlook is cautious; clean energy demand offers long-term growth, but PBW's high sensitivity to Treasury yields and tech sector swings poses near-term risks. Investors should weigh sector optimism against macroeconomic headwinds and the ETF's history of volatility during rate cycles.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →